Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants

We aimed to explore the genotypic and phenotypic characteristics of neonatal-onset inflammatory bowel disease (IBD) with combined immunodeficiency due to TTC7A mutation. We examined the clinical manifestations, imaging results, endoscopic and histological findings, interventions, and prognosis of a...

Full description

Bibliographic Details
Main Authors: Yun-e Chen, Jingfang Chen, Wenxing Guo, Yanhong Zhang, Jialing Li, Hui Xie, Tong Shen, Yunsheng Ge, Yanru Huang, Wenying Zheng, Mei Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.921808/full
_version_ 1811242585992200192
author Yun-e Chen
Jingfang Chen
Wenxing Guo
Yanhong Zhang
Jialing Li
Hui Xie
Tong Shen
Yunsheng Ge
Yanru Huang
Wenying Zheng
Mei Lu
author_facet Yun-e Chen
Jingfang Chen
Wenxing Guo
Yanhong Zhang
Jialing Li
Hui Xie
Tong Shen
Yunsheng Ge
Yanru Huang
Wenying Zheng
Mei Lu
author_sort Yun-e Chen
collection DOAJ
description We aimed to explore the genotypic and phenotypic characteristics of neonatal-onset inflammatory bowel disease (IBD) with combined immunodeficiency due to TTC7A mutation. We examined the clinical manifestations, imaging results, endoscopic and histological findings, interventions, and prognosis of a proband with neonatal-onset IBD and performed biochemical analyses, whole-exome sequencing (WES), and in silico analysis. Our proband developed severe early-onset diarrhea, malnutrition, electrolyte imbalance, dehydration, and recurrent infections after birth. Radiographic and ultrasonic images showed no specific manifestations. Endoscopic and histological examination revealed chronic inflammation. Immune function examination indicated immunodeficiency. WES identified compound heterozygous TTC7A mutations (c.2355+4A>G, c.643G>T) in the proband. In the expression analysis, no abnormal splicing in the TTC7A sequence was observed due to the c.2355+4A>G mutation; however, the mRNA expression was reduced. The proband’s condition did not improve after treatment with methylprednisolone or leflunomide. The proband died when treatment was stopped at the age of 5 months and 19 days. Compound heterozygous mutations (c.2355+4A>G, c.643G>T) in the TTC7A gene are described and verified for the first time. Our report expands the phenotypic spectrum of TTC7A mutations and the genotypic spectrum of very early-onset IBD with combined immunodeficiency.
first_indexed 2024-04-12T13:53:19Z
format Article
id doaj.art-b492a6bf2cfa454cac2cdc93f709ed21
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-12T13:53:19Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-b492a6bf2cfa454cac2cdc93f709ed212022-12-22T03:30:26ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-06-011310.3389/fgene.2022.921808921808Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A VariantsYun-e Chen0Jingfang Chen1Wenxing Guo2Yanhong Zhang3Jialing Li4Hui Xie5Tong Shen6Yunsheng Ge7Yanru Huang8Wenying Zheng9Mei Lu10Department of Pediatrics, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Gastroenterology, Xiamen Branch of the Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Xiamen, ChinaDepartment of Pediatrics, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Ultrasound Medicine, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Gastroenterology, Xiamen Branch of the Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Xiamen, ChinaDepartment of Pediatrics, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Pediatrics, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaPrenatal Diagnostic Center Laboratory, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaPrenatal Diagnostic Center Laboratory, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaGenokon Institute of Medical Science and Laboratory, Xiamen, ChinaDepartment of Pediatrics, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, ChinaWe aimed to explore the genotypic and phenotypic characteristics of neonatal-onset inflammatory bowel disease (IBD) with combined immunodeficiency due to TTC7A mutation. We examined the clinical manifestations, imaging results, endoscopic and histological findings, interventions, and prognosis of a proband with neonatal-onset IBD and performed biochemical analyses, whole-exome sequencing (WES), and in silico analysis. Our proband developed severe early-onset diarrhea, malnutrition, electrolyte imbalance, dehydration, and recurrent infections after birth. Radiographic and ultrasonic images showed no specific manifestations. Endoscopic and histological examination revealed chronic inflammation. Immune function examination indicated immunodeficiency. WES identified compound heterozygous TTC7A mutations (c.2355+4A>G, c.643G>T) in the proband. In the expression analysis, no abnormal splicing in the TTC7A sequence was observed due to the c.2355+4A>G mutation; however, the mRNA expression was reduced. The proband’s condition did not improve after treatment with methylprednisolone or leflunomide. The proband died when treatment was stopped at the age of 5 months and 19 days. Compound heterozygous mutations (c.2355+4A>G, c.643G>T) in the TTC7A gene are described and verified for the first time. Our report expands the phenotypic spectrum of TTC7A mutations and the genotypic spectrum of very early-onset IBD with combined immunodeficiency.https://www.frontiersin.org/articles/10.3389/fgene.2022.921808/fullinflammatory bowel diseaseimmunodeficiencyneonatalTTC7Aintervention
spellingShingle Yun-e Chen
Jingfang Chen
Wenxing Guo
Yanhong Zhang
Jialing Li
Hui Xie
Tong Shen
Yunsheng Ge
Yanru Huang
Wenying Zheng
Mei Lu
Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants
Frontiers in Genetics
inflammatory bowel disease
immunodeficiency
neonatal
TTC7A
intervention
title Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants
title_full Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants
title_fullStr Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants
title_full_unstemmed Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants
title_short Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants
title_sort clinical characteristics in silico analysis and intervention of neonatal onset inflammatory bowel disease with combined immunodeficiency caused by novel ttc7a variants
topic inflammatory bowel disease
immunodeficiency
neonatal
TTC7A
intervention
url https://www.frontiersin.org/articles/10.3389/fgene.2022.921808/full
work_keys_str_mv AT yunechen clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT jingfangchen clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT wenxingguo clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT yanhongzhang clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT jialingli clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT huixie clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT tongshen clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT yunshengge clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT yanruhuang clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT wenyingzheng clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants
AT meilu clinicalcharacteristicsinsilicoanalysisandinterventionofneonatalonsetinflammatoryboweldiseasewithcombinedimmunodeficiencycausedbynovelttc7avariants